KRAS and cancer: This phylogenetic analysis of SINA/SIAH evolution in the animal kingdom is likely to provide valuable insights into the logical design of effective anti-K-RAS drugs that selectively target and specifically inhibit human SIAH1/2 proteins to rapidly shut down oncogenic K-RAS-driven malignant tumor growth and block metastatic cancer cell dissemination.